Regulatory Pathway for Licensing Biotherapeutics in Mexico

Biotherapeutic products which are derived from living organisms using recombinant DNA technology significantly contribute to the progress in the treatment of life-threatening and chronic diseases. The worldwide sale of biological drugs in 2016 was near US $263,700 million. In Latin America, where mo...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Front Med (Lausanne)
Main Authors: López-Morales, Carlos A., Tenorio-Calvo, Alejandra, Cruz-Rodríguez, Rodolfo, Sánchez y Tepoz, Julio, Belgharbi, Lahouari, Pérez-Tapia, Sonia Mayra, Medina-Rivero, Emilio
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2018
Teme:
Medicine
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6167464/
https://ncbi.nlm.nih.gov/pubmed/30320117
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2018.00272
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki